Terms: = Ovarian cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4 AND Prognosis
96 results:
1. Correlation of clinicopathological and prognostic characteristics between endometriosis-associated and primary ovarian cancer.
Wang H; Chen C; Wang D; Zhu Y; Chen P
BMC Cancer; 2023 Dec; 23(1):1210. PubMed ID: 38066448
[TBL] [Abstract] [Full Text] [Related]
2. TP53 mutation and human papilloma virus status as independent prognostic factors in a Norwegian cohort of vulva squamous cell carcinoma.
Dongre HN; Elnour R; Tornaas S; Fromreide S; Thomsen LCV; Kolseth IBM; Nginamau ES; Johannessen AC; Vintermyr OK; Costea DE; Bjørge L
Acta Obstet Gynecol Scand; 2024 Jan; 103(1):165-175. PubMed ID: 37840151
[TBL] [Abstract] [Full Text] [Related]
3. The Identification of Gamma-Glutamyl Hydrolase in Uterine Corpus Endometrial Carcinoma: a Predictive Model and Machine Learning.
Zhu C; Du Y; Huai Q; Fang N; Xu W; Yang J; Li X; Zhang Y; Zhang X; Dai H; Li X; Wang H; Dai Y
Reprod Sci; 2024 Feb; 31(2):532-549. PubMed ID: 37798609
[TBL] [Abstract] [Full Text] [Related]
4. PTEN deficiency exposes a requirement for an arf GTPase module for integrin-dependent invasion in ovarian cancer.
Nikolatou K; Sandilands E; Román-Fernández A; Cumming EM; Freckmann E; Lilla S; Buetow L; McGarry L; Neilson M; Shaw R; Strachan D; Miller C; Huang DT; McNeish IA; Norman JC; Zanivan S; Bryant DM
EMBO J; 2023 Sep; 42(18):e113987. PubMed ID: 37577760
[TBL] [Abstract] [Full Text] [Related]
5. The usefulness of p16 and COX-2 expression on the prediction of progression to endometrial cancer.
Kalkan HE; Akman L; Serin G; Terek MC; Zekioglu O; Ozsaran AA
Histol Histopathol; 2024 May; 39(5):565-571. PubMed ID: 37503793
[TBL] [Abstract] [Full Text] [Related]
6. Clinical Outcome and Morphology-Based Analysis of p53 Aberrant and Mismatch Repair Protein-Deficient ovarian Clear Cell Carcinoma and Their Association With p16, HER2, and PD-L1 Expression.
Wilkins R; Lin LH; Xia R; Shiomi T; Zamuco RD; Shukla PS
Am J Clin Pathol; 2023 Nov; 160(5):466-476. PubMed ID: 37415414
[TBL] [Abstract] [Full Text] [Related]
7. A comprehensive immunohistochemical analysis of 26 markers in 250 cases of serous ovarian tumors.
Němejcová K; Šafanda A; Bártů MK; Michálková R; Drozenová J; Fabian P; Hausnerová J; Laco J; Matěj R; Méhes G; Škapa P; Stružinská I; Dundr P
Diagn Pathol; 2023 Feb; 18(1):32. PubMed ID: 36855066
[TBL] [Abstract] [Full Text] [Related]
8. MTA1 as negative prognostic marker in vulvar carcinoma.
Wanka G; Jueckstock J; Wild CM; Vattai A; Fürst S; Heidegger HH; Kuhn C; Schmoeckel E; Jeschke U; Dannecker C
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6191-6201. PubMed ID: 36689059
[TBL] [Abstract] [Full Text] [Related]
9. m
Fang F; Wang P; Huang H; Ye M; Liu X; Li Q
BMC Cancer; 2022 Dec; 22(1):1364. PubMed ID: 36581816
[TBL] [Abstract] [Full Text] [Related]
10. Molecular Evidence for Epithelial Origin of Mixed ovarian Epithelial-Germ Cell Neoplasms: Report of 2 Cases and Review of Literature.
Hall KC; Post MD; Alldredge J; Aisner DL; Berning A
Int J Gynecol Pathol; 2023 Jul; 42(4):403-413. PubMed ID: 36305517
[TBL] [Abstract] [Full Text] [Related]
11. A bioinformatics analysis: ZFHX4 is associated with metastasis and poor survival in ovarian cancer.
Zong S; Xu PP; Xu YH; Guo Y
J Ovarian Res; 2022 Aug; 15(1):90. PubMed ID: 35915456
[TBL] [Abstract] [Full Text] [Related]
12. Membranous and nuclear staining of CLDN18 in HPV-independent and HPV-associated endocervical adenocarcinomas.
Du X; Hu Y; Ji X; Sui L; Zheng Q; Song K; Lv T; Chen Y; Zhao H; Dai S; Zhao P; Yao Q
Cancer Med; 2023 Jan; 12(2):1441-1450. PubMed ID: 35861118
[TBL] [Abstract] [Full Text] [Related]
13. Somatic genomic landscape of East Asian epithelial ovarian carcinoma and its clinical implications from prospective clinical sequencing: A Korean Gynecologic Oncology Group study (KGOG 3047).
Sa JK; Kim J; Kang S; Kim SW; Song T; Shim SH; Choi MC; No JH; Song JY; Kim D; Kim YM; Kim JH; Lee JW
Int J Cancer; 2022 Oct; 151(7):1086-1097. PubMed ID: 35666535
[TBL] [Abstract] [Full Text] [Related]
14. [Primary ovarian squamous cell carcinoma: clinicopathological features and prognostic analysis of fifteen cases].
Xi Y; Zhang ML; He C; Cheng GP; Jin JY; Fang XH; Zhu T; Su D
Zhonghua Bing Li Xue Za Zhi; 2022 Apr; 51(4):332-337. PubMed ID: 35359045
[No Abstract] [Full Text] [Related]
15. Identification of a novel nine-SnoRNA signature with potential prognostic and therapeutic value in ovarian cancer.
Zhu W; Zhang T; Luan S; Kong Q; Hu W; Zou X; Zheng F; Han W
Cancer Med; 2022 May; 11(10):2159-2170. PubMed ID: 35187852
[TBL] [Abstract] [Full Text] [Related]
16. Integrated Bioinformatics Analysis for Identification of the Hub Genes Linked with prognosis of ovarian cancer Patients.
Li X; Wang Q; Wu Z; Zheng J; Ji L
Comput Math Methods Med; 2022; 2022():5113447. PubMed ID: 35047055
[TBL] [Abstract] [Full Text] [Related]
17. Clinical factors and biomarker profiles associated with patient outcome in endometrioid ovarian carcinoma - Emphasis on tumor grade.
Soovares P; Pasanen A; Similä-Maarala J; Bützow R; Lassus H
Gynecol Oncol; 2022 Jan; 164(1):187-194. PubMed ID: 34711431
[TBL] [Abstract] [Full Text] [Related]
18. [Clinicopathological features of malignant mixed mesodermal tumor: analysis of 50 cases].
Ding XH; Ma ZY; Wang YF; Dou FX; Yuan J; Tian X; Liu AJ
Zhonghua Bing Li Xue Za Zhi; 2021 Sep; 50(9):1008-1013. PubMed ID: 34496490
[No Abstract] [Full Text] [Related]
19. Hereditary pancreatic cancer.
Abe K; Kitago M; Kitagawa Y; Hirasawa A
Int J Clin Oncol; 2021 Oct; 26(10):1784-1792. PubMed ID: 34476650
[TBL] [Abstract] [Full Text] [Related]
20. A "Null" Pattern of p16 Immunostaining in Endometrial Serous Carcinoma: An Under-recognized and Important Aberrant Staining Pattern.
Matson DR; Accola MA; Henderson L; Shao X; Frater-Rubsam L; Horner VL; Rehrauer WM; Weisman P; Xu J
Int J Gynecol Pathol; 2022 Jul; 41(4):378-388. PubMed ID: 34380970
[TBL] [Abstract] [Full Text] [Related]
[Next]
